Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection

Abstract This cross-sectional study evaluated the performance of the Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) and the Fibrosis-4 (FIB-4) Index when they were used individually and in sequential combination to diagnose cirrhosis associated with hepatitis C virus infection. The final...

Full description

Bibliographic Details
Main Authors: Mohd Azri Mohd Suan, Huan Keat Chan, Xiaohui Sem, Sonjelle Shilton, Muhammad Radzi Abu Hassan
Format: Article
Language:English
Published: Nature Portfolio 2022-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-24612-9
_version_ 1797986893384646656
author Mohd Azri Mohd Suan
Huan Keat Chan
Xiaohui Sem
Sonjelle Shilton
Muhammad Radzi Abu Hassan
author_facet Mohd Azri Mohd Suan
Huan Keat Chan
Xiaohui Sem
Sonjelle Shilton
Muhammad Radzi Abu Hassan
author_sort Mohd Azri Mohd Suan
collection DOAJ
description Abstract This cross-sectional study evaluated the performance of the Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) and the Fibrosis-4 (FIB-4) Index when they were used individually and in sequential combination to diagnose cirrhosis associated with hepatitis C virus infection. The final evaluation involved 906 people living with hepatitis C. The diagnostic performance of individual biomarkers at cut-off scores of 1.5 and 2.0 for the APRI and at 3.25 for the FIB-4 index was assessed. For the sequential combination method, the cirrhosis status of individuals with an APRI score between 1.0 and 1.5 were reassessed using the FIB-4. Transient elastography (TE) was used as the reference standard for diagnosing cirrhosis. The APRI, at a cut-off score of 1.5, showed a sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 44.9%, 97.6%, 91.1% and 76.3%, respectively. Increasing the cut-off score to 2.0 produced a much lower sensitivity (29.6%) and NPV (71.9%). The FIB-4, at a cut-off score of 3.25, yielded a sensitivity, specificity, PPV and NPV of 40.8%, 97.3%, 89.1% and 75.0%, respectively. The sequential combination method demonstrated a much more optimal diagnostic performance (50.2% sensitivity, 96.6% specificity, 89.0% PPV and 77.9% NPV). Overall, the APRI and FIB-4 Index performed better in diagnosing cirrhosis associated with hepatitis C when they were used in sequential combination.
first_indexed 2024-04-11T07:39:08Z
format Article
id doaj.art-fdcef962a391413e9a08ca097f45bb42
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-11T07:39:08Z
publishDate 2022-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-fdcef962a391413e9a08ca097f45bb422022-12-22T04:36:38ZengNature PortfolioScientific Reports2045-23222022-11-011211810.1038/s41598-022-24612-9Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infectionMohd Azri Mohd Suan0Huan Keat Chan1Xiaohui Sem2Sonjelle Shilton3Muhammad Radzi Abu Hassan4Clinical Research Centre, Hospital Sultanah Bahiyah, Ministry of HealthClinical Research Centre, Hospital Sultanah Bahiyah, Ministry of HealthFINDFINDOffice of Deputy Director General, Ministry of Health MalaysiaAbstract This cross-sectional study evaluated the performance of the Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) and the Fibrosis-4 (FIB-4) Index when they were used individually and in sequential combination to diagnose cirrhosis associated with hepatitis C virus infection. The final evaluation involved 906 people living with hepatitis C. The diagnostic performance of individual biomarkers at cut-off scores of 1.5 and 2.0 for the APRI and at 3.25 for the FIB-4 index was assessed. For the sequential combination method, the cirrhosis status of individuals with an APRI score between 1.0 and 1.5 were reassessed using the FIB-4. Transient elastography (TE) was used as the reference standard for diagnosing cirrhosis. The APRI, at a cut-off score of 1.5, showed a sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 44.9%, 97.6%, 91.1% and 76.3%, respectively. Increasing the cut-off score to 2.0 produced a much lower sensitivity (29.6%) and NPV (71.9%). The FIB-4, at a cut-off score of 3.25, yielded a sensitivity, specificity, PPV and NPV of 40.8%, 97.3%, 89.1% and 75.0%, respectively. The sequential combination method demonstrated a much more optimal diagnostic performance (50.2% sensitivity, 96.6% specificity, 89.0% PPV and 77.9% NPV). Overall, the APRI and FIB-4 Index performed better in diagnosing cirrhosis associated with hepatitis C when they were used in sequential combination.https://doi.org/10.1038/s41598-022-24612-9
spellingShingle Mohd Azri Mohd Suan
Huan Keat Chan
Xiaohui Sem
Sonjelle Shilton
Muhammad Radzi Abu Hassan
Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection
Scientific Reports
title Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection
title_full Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection
title_fullStr Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection
title_full_unstemmed Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection
title_short Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection
title_sort diagnostic performance of two non invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis c virus infection
url https://doi.org/10.1038/s41598-022-24612-9
work_keys_str_mv AT mohdazrimohdsuan diagnosticperformanceoftwononinvasivebiomarkersusedindividuallyandinsequentialcombinationforcirrhosisassociatedwithhepatitiscvirusinfection
AT huankeatchan diagnosticperformanceoftwononinvasivebiomarkersusedindividuallyandinsequentialcombinationforcirrhosisassociatedwithhepatitiscvirusinfection
AT xiaohuisem diagnosticperformanceoftwononinvasivebiomarkersusedindividuallyandinsequentialcombinationforcirrhosisassociatedwithhepatitiscvirusinfection
AT sonjelleshilton diagnosticperformanceoftwononinvasivebiomarkersusedindividuallyandinsequentialcombinationforcirrhosisassociatedwithhepatitiscvirusinfection
AT muhammadradziabuhassan diagnosticperformanceoftwononinvasivebiomarkersusedindividuallyandinsequentialcombinationforcirrhosisassociatedwithhepatitiscvirusinfection